Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Manocha

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Critical Care Medicine|January 11, 2005
Activated protein C: beyond 28 daysSanjay Manocha, Keith R Walley
Critical Care Medicine|November 8, 2003
Severe acute respiratory distress syndrome (SARS): a critical care perspectiveSanjay Manocha, Keith R Walley, James A Russell
Healthcare Quarterly (Toronto, Ont.)|April 26, 2020
Smartphone Technology: Impact on Interprofessional Working Relations between Doctors and NursesSanjay Manocha, Jamie Spiegelman, Ethan Miller, et al.
Expert Opinion on Investigational Drugs|November 30, 2002
Novel therapies for sepsis: antiendotoxin therapiesSanjay Manocha, Daniel Feinstein, Aseem Kumar, et al.
Archives of Internal Medicine|January 12, 2005
The association of interleukin 6 haplotype clades with mortality in critically ill adultsAinsley M Sutherland, Keith R Walley, Sanjay Manocha, et al.
Critical Care (London, England)|August 18, 2004
Mechanisms of beta-receptor stimulation-induced improvement of acute lung injury and pulmonary edemaHoracio E Groshaus, Sanjay Manocha, Keith R Walley, et al.
Chest|September 16, 2005
Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsisAnan Wattanathum, Sanjay Manocha, Horacio Groshaus, et al.
The Journal of Infection|November 23, 2006
Fibrinogen-beta gene haplotype is associated with mortality in sepsisSanjay Manocha, James A Russell, Ainsley M Sutherland, et al.
Critical Care (London, England)|January 20, 2006
Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injurySanjay Manocha, Anthony C Gordon, Ebrahim Salehifar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Critical Care Medicine|January 11, 2005
Activated protein C: beyond 28 daysSanjay Manocha, Keith R Walley
Critical Care Medicine|November 8, 2003
Severe acute respiratory distress syndrome (SARS): a critical care perspectiveSanjay Manocha, Keith R Walley, James A Russell
Healthcare Quarterly (Toronto, Ont.)|April 26, 2020
Smartphone Technology: Impact on Interprofessional Working Relations between Doctors and NursesSanjay Manocha, Jamie Spiegelman, Ethan Miller, et al.
Expert Opinion on Investigational Drugs|November 30, 2002
Novel therapies for sepsis: antiendotoxin therapiesSanjay Manocha, Daniel Feinstein, Aseem Kumar, et al.
Archives of Internal Medicine|January 12, 2005
The association of interleukin 6 haplotype clades with mortality in critically ill adultsAinsley M Sutherland, Keith R Walley, Sanjay Manocha, et al.
Critical Care (London, England)|August 18, 2004
Mechanisms of beta-receptor stimulation-induced improvement of acute lung injury and pulmonary edemaHoracio E Groshaus, Sanjay Manocha, Keith R Walley, et al.
Chest|September 16, 2005
Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsisAnan Wattanathum, Sanjay Manocha, Horacio Groshaus, et al.
The Journal of Infection|November 23, 2006
Fibrinogen-beta gene haplotype is associated with mortality in sepsisSanjay Manocha, James A Russell, Ainsley M Sutherland, et al.
Critical Care (London, England)|January 20, 2006
Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injurySanjay Manocha, Anthony C Gordon, Ebrahim Salehifar, et al.
Pageof 1